https://commons.ru.ac.za/vital/access/manager/Index en-us 5 Stability indicating HPLC-ECD method for the analysis of clarithromycin in pharmaceutical dosage forms: Method scaling versus re-validation. https://commons.ru.ac.za/vital/access/manager/Repository/vital:43984 Wed 07 Aug 2024 13:28:25 SAST ]]> Assessment of taste masking of captopril by ion-exchange resins using electronic gustatory system https://commons.ru.ac.za/vital/access/manager/Repository/vital:44265 Wed 07 Aug 2024 13:28:21 SAST ]]> Nano-biomimetic drug delivery vehicles: Potential approaches for COVID-19 treatment https://commons.ru.ac.za/vital/access/manager/Repository/vital:43991 Tue 14 May 2024 11:13:22 SAST ]]> Formulation and Characterisation of a Combination Captopril and Hydrochlorothiazide Microparticulate Dosage Form https://commons.ru.ac.za/vital/access/manager/Repository/vital:43926 75% for both hydrochlorothiazide and captopril. The microparticulate technology is able to offer potential resolution to the half-life mediated dosing frequency of captopril as sustained release of the molecule was observed over a 12-h period. The release of hydrochlorothiazide of >80% suggests an improvement in solubility limited dissolution.]]> Tue 14 May 2024 10:56:57 SAST ]]>